IDEXX Laboratories, Inc. (IDXX) Investor Relations Documents

IDEXX Laboratories, Inc. (IDXX) investor relations documents from the company's IR site: 11 presentations, 29 press releases; latest deck 2026-08-04. Read in-app with summaries. First-party data.

Earnings snapshot PDF: IDEXX Q2 2026 earnings show $1,217M revenue and $4.27 EPS, with full-year guidance raised due to strong CAG Diagnostics recurring revenue.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-11Press releaseIDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test
2026-08-04Earnings deckEarnings snapshot PDF
2026-08-04Press releaseIDEXX Laboratories Announces Second Quarter Results
2026-07-28Press releaseIDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals
2026-07-01Press releaseIDEXX Laboratories to Release 2026 Second Quarter Financial Results
2026-05-26Press releaseIDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection
2026-05-19Press releaseIDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles
2026-05-14Press releaseIDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day
2026-05-05Press releaseEarnings release Q1 2026 PDF
2026-05-05Earnings deckPDF
2026-05-05Press releasePDF
2026-04-08Press releaseIDEXX Laboratories to Release 2026 First Quarter Financial Results
2026-03-02PresentationRaymond James Institutional Investors Conference Presentation
2026-02-12Press releaseIDEXX Laboratories to Present at Two Institutional Investor Conferences
2026-02-02PresentationEarnings snapshotPDF
2026-02-02Press releaseIDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results
2026-01-15Press releaseLowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus
2026-01-09Press releaseIDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results
Press releaseIDEXX Laboratories Announces Third Quarter Results
2025-11-03PresentationEarnings snapshotPDF
2025-10-08Press releaseIDEXX Laboratories to Release 2025 Third Quarter Financial Results
2025-08-14PresentationIDEXX Investor Day presentation
2025-08-04PresentationEarnings snapshotPDF
2025-08-04Press releaseIDEXX Laboratories Announces Second Quarter Results
2025-07-30Press releaseIDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals
2025-06-24Press releaseIDEXX Laboratories to Release 2025 Second Quarter Financial Results
2025-05-13Press releaseIDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day
2025-05-01Press releaseIDEXX Laboratories Announces First Quarter Results
2025-04-30PresentationEarnings snapshotPDF
2025-04-03Press releaseIDEXX Laboratories to Release 2025 First Quarter Financial Results
2025-02-03PresentationEarnings snapshotPDF
2025-02-03Press releaseIDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
2025-01-16Press releaseIDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results
2024-10-31PresentationEarnings snapshotPDF
2024-10-31Press releaseCORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
2024-09-30Press releaseIDEXX Laboratories to Release 2024 Third Quarter Financial Results
2024-08-06PresentationEarnings snapshotPDF
2024-08-06Press releaseIDEXX Laboratories Announces Second Quarter Results
2024-07-30Press releaseIDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals
2024-07-30Press releaseIDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call

IDXX overview · IDXX earnings · IDXX financials · IDXX KPIs · IDXX documents · IDXX ownership · IDXX peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.